The Orphan Drug Act has catalyzed innovation in rare disease treatments, but the law’s shortcomings — particularly around ...
In 1983, Congress passed the Orphan Drug Act (“ODA”) as part of an effort to provide market incentives for pharmaceutical manufacturers to produce “orphan drugs,” drugs for diseases that impact less ...
New Zealand's mainstay drug law turned 50 this year—yet we still don't have a clear, comprehensive picture of the social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback